Literature DB >> 10534153

Evidence of stavudine-related phenotypic resistance among zidovudine-pretreated HIV-1-infected subjects receiving a therapeutic regimen of stavudine plus lamivudine.

L Milazzo, S Rusconi, L Testa, S La Seta-Catamancio, M Galazzi, S Kurtagic, P Citterio, M Gianotto, A Grassini, F Adorni, A d'Arminio-Monforte, M Galli, M Moroni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10534153     DOI： 10.1097/00042560-199909010-00013

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  3 in total

1.  Response to antiretroviral therapy in a patient with an uncommon codon 69 insertion in the human immunodeficiency virus type 1 reverse transcriptase.

Authors:  P Bonfanti; I Faggion; S La Seta Catamancio; M Violin; C Balotta; S Rusconi
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

2.  Hypersusceptibility to substrate analogs conferred by mutations in human immunodeficiency virus type 1 reverse transcriptase.

Authors:  Robert A Smith; Donovan J Anderson; Bradley D Preston
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

3.  Discordance between genotypic and phenotypic drug resistance profiles in human immunodeficiency virus type 1 strains isolated from peripheral blood mononuclear cells.

Authors:  Loredana Sarmati; Emanuele Nicastri; Saverio G Parisi; Gabriella d'Ettorre; Giorgio Mancino; Pasquale Narciso; Vincenzo Vullo; Massimo Andreoni
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.